These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31639498)

  • 1. Avian interspecific differences in VKOR activity and inhibition: Insights from amino acid sequence and mRNA expression ratio of VKORC1 and VKORC1L1.
    Nakayama SMM; Morita A; Ikenaka Y; Kawai YK; Watanabe KP; Ishii C; Mizukawa H; Yohannes YB; Saito K; Watanabe Y; Ito M; Ohsawa N; Ishizuka M
    Comp Biochem Physiol C Toxicol Pharmacol; 2020 Feb; 228():108635. PubMed ID: 31639498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VKORC1 and VKORC1L1 have distinctly different oral anticoagulant dose-response characteristics and binding sites.
    Czogalla KJ; Liphardt K; Höning K; Hornung V; Biswas A; Watzka M; Oldenburg J
    Blood Adv; 2018 Mar; 2(6):691-702. PubMed ID: 29581108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VKORC1L1, an enzyme rescuing the vitamin K 2,3-epoxide reductase activity in some extrahepatic tissues during anticoagulation therapy.
    Hammed A; Matagrin B; Spohn G; Prouillac C; Benoit E; Lattard V
    J Biol Chem; 2013 Oct; 288(40):28733-42. PubMed ID: 23928358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VKORC1L1, An Enzyme Mediating the Effect of Vitamin K in Liver and Extrahepatic Tissues.
    Lacombe J; Ferron M
    Nutrients; 2018 Jul; 10(8):. PubMed ID: 30050002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VKOR paralog VKORC1L1 supports vitamin K-dependent protein carboxylation in vivo.
    Lacombe J; Rishavy MA; Berkner KL; Ferron M
    JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two enzymes catalyze vitamin K 2,3-epoxide reductase activity in mouse: VKORC1 is highly expressed in exocrine tissues while VKORC1L1 is highly expressed in brain.
    Caspers M; Czogalla KJ; Liphardt K; Müller J; Westhofen P; Watzka M; Oldenburg J
    Thromb Res; 2015 May; 135(5):977-83. PubMed ID: 25747820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin resistance in a French strain of rats.
    Lasseur R; Longin-Sauvageon C; Videmann B; Billeret M; Berny P; Benoit E
    J Biochem Mol Toxicol; 2005; 19(6):379-85. PubMed ID: 16421894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of warfarin-binding pocket of VKORC1 and VKORL1 by a peripheral region determines their different sensitivity to warfarin inhibition.
    Shen G; Li S; Cui W; Liu S; Liu Q; Yang Y; Gross M; Li W
    J Thromb Haemost; 2018 Jun; 16(6):1164-1175. PubMed ID: 29665197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of warfarin resistance using transcription activator-like effector nucleases-mediated vitamin K epoxide reductase knockout HEK293 cells.
    Tie JK; Jin DY; Tie K; Stafford DW
    J Thromb Haemost; 2013 Aug; 11(8):1556-64. PubMed ID: 23710884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of anticoagulant rodenticide sensitivity by examining in vivo and in vitro responses in avian species, focusing on raptors.
    Khidkhan K; Yasuhira F; Saengtienchai A; Kasorndorkbua C; Sitdhibutr R; Ogasawara K; Adachi H; Watanabe Y; Saito K; Sakai H; Horikoshi K; Suzuki H; Kawai YK; Takeda K; Yohannes YB; Ikenaka Y; Rattner BA; Ishizuka M; Nakayama SMM
    Environ Pollut; 2024 Jan; 341():122837. PubMed ID: 37931675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The VKORC1 ER-luminal loop mutation (Leu76Pro) leads to a significant resistance to warfarin in black rats (Rattus rattus).
    Takeda K; Ikenaka Y; Fourches D; Tanaka KD; Nakayama SMM; Triki D; Li X; Igarashi M; Tanikawa T; Ishizuka M
    Pestic Biochem Physiol; 2021 Mar; 173():104774. PubMed ID: 33771253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confirmation of warfarin resistance of naturally occurring VKORC1 variants by coexpression with coagulation factor IX and in silico protein modelling.
    Müller E; Keller A; Fregin A; Müller CR; Rost S
    BMC Genet; 2014 Feb; 15():17. PubMed ID: 24491178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation in VKORC1 and its effect on enzymatic activity in Japanese warfarin-resistant rats.
    Tanaka KD; Kawai YK; Ikenaka Y; Harunari T; Tanikawa T; Fujita S; Ishizuka M
    J Vet Med Sci; 2013 Feb; 75(2):135-9. PubMed ID: 23018795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetic basis of resistance to anticoagulants in rodents.
    Pelz HJ; Rost S; Hünerberg M; Fregin A; Heiberg AC; Baert K; MacNicoll AD; Prescott CV; Walker AS; Oldenburg J; Müller CR
    Genetics; 2005 Aug; 170(4):1839-47. PubMed ID: 15879509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2.
    Rost S; Fregin A; Ivaskevicius V; Conzelmann E; Hörtnagel K; Pelz HJ; Lappegard K; Seifried E; Scharrer I; Tuddenham EG; Müller CR; Strom TM; Oldenburg J
    Nature; 2004 Feb; 427(6974):537-41. PubMed ID: 14765194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new cell culture-based assay quantifies vitamin K 2,3-epoxide reductase complex subunit 1 function and reveals warfarin resistance phenotypes not shown by the dithiothreitol-driven VKOR assay.
    Fregin A; Czogalla KJ; Gansler J; Rost S; Taverna M; Watzka M; Bevans CG; Müller CR; Oldenburg J
    J Thromb Haemost; 2013 May; 11(5):872-80. PubMed ID: 23452238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human VKORC1 mutations cause variable degrees of 4-hydroxycoumarin resistance and affect putative warfarin binding interfaces.
    Czogalla KJ; Biswas A; Wendeln AC; Westhofen P; Müller CR; Watzka M; Oldenburg J
    Blood; 2013 Oct; 122(15):2743-50. PubMed ID: 23982176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pesticide resistance in wild mammals--mechanisms of anticoagulant resistance in wild rodents.
    Ishizuka M; Tanikawa T; Tanaka KD; Heewon M; Okajima F; Sakamoto KQ; Fujita S
    J Toxicol Sci; 2008 Aug; 33(3):283-91. PubMed ID: 18670159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: evidence that highly conserved amino acids define structural requirements for enzymatic activity and inhibition by warfarin.
    Rost S; Fregin A; Hünerberg M; Bevans CG; Müller CR; Oldenburg J
    Thromb Haemost; 2005 Oct; 94(4):780-6. PubMed ID: 16270630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conserved loop cysteines of vitamin K epoxide reductase complex subunit 1-like 1 (VKORC1L1) are involved in its active site regeneration.
    Tie JK; Jin DY; Stafford DW
    J Biol Chem; 2014 Mar; 289(13):9396-407. PubMed ID: 24532791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.